Established in 1966, Qianjin Pharmaceutical Co., Ltd. was restructured through the shareholding system reform in 1993 and was listed on Shanghai Stock Exchange in 2004. We have 11 subsidiaries with around 8,000 employees. Our business covers Chinese patent medicines, drugs & drug substances, TCM related products, drug wholesale & retail, Chinese crude drugs planting & processing, etc.
In 2006, our staple Fuke Qianjin Tablets was recognized as "Technology of National Secrecy". Fuke Qianjin Tablets (Capsules) has been a Class A drug in the National Reimbursement Drug List (NRDL) since 1998 and was on the list of the National Essential Drug List (NEDL) in 2009, 2012 and 2018. Since 2010, Buxue Yimu Pills (Granules) has been embodied into the NRDL and was an NEDL drug in 2018.
From 2008, the brand "Qianjin" ranked in "Health China·Brand List" by China Health Ecology Organization (CHEO) for 15 years.
